Detalles de la búsqueda
1.
Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
Diabetes Obes Metab
; 18(11): 1093-1097, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27484021
2.
Relationship of apolipoprotein A5 and apolipoprotein C3 levels to serum triglycerides in patients with type 2 diabetes.
Clin Chim Acta
; 378(1-2): 154-8, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17188674
3.
Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus® Insulin Glargine.
Diabetes Ther
; 8(3): 545-554, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28361463
4.
Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes.
J Am Diet Assoc
; 103(12): 1607-12, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-14647086
5.
Lower glucose variability and hypoglycemia measured by continuous glucose monitoring with novel long-acting insulin LY2605541 versus insulin glargine.
Diabetes Care
; 37(3): 659-65, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24198302
6.
Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects.
Diabetes Care
; 37(9): 2609-15, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947791
7.
The effect of adjusting for baseline hypoglycemia when analyzing hypoglycemia data: a systematic analysis of 15 diabetes clinical trials.
Diabetes Technol Ther
; 15(8): 654-61, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23883405
8.
Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study.
Diabetes Care
; 36(3): 522-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23193209
9.
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
Diabetes Care
; 35(11): 2140-7, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22787177
10.
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.
Diabetes Care
; 36(7): e107-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801809
11.
Definitive N-terminal protein sequence and further characterization of the novel apolipoprotein A5 in human serum.
Clin Chem
; 52(3): 514-7, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16510431
Resultados
1 -
11
de 11
1
Próxima >
>>